Venker Eric's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Oct 8, 2025
- Accession no.
- 0001140361-25-037740
- Filed
- Oct 8, 2025
- Trade date
- Oct 6-8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 11 non-derivative transactions and 8 derivative transactions. Open-market sales total $10.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Venker EricCIK 0001801917 | Officer (President & Immunovant CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Shares | MOption exerciseAcquired | +127,355 | $15.85 | +$2,018,576.75 | 1,632,314 | Direct | |
| Oct 6, 2025 | Common Shares | MOption exerciseAcquired | +24,900 | $7.45 | +$185,505 | 1,657,214 | Direct | |
| Oct 6, 2025 | Common Shares | MOption exerciseAcquired | +19,141 | $3.85 | +$73,692.85 | 1,676,355 | Direct | |
| Oct 6, 2025 | Common Shares | SSaleDisposed | −171,396 | $16.34 | −$2,800,610.64 | 1,504,959 | Direct | |
| Oct 7, 2025 | Common Shares | MOption exerciseAcquired | +67,171 | $15.85 | +$1,064,660.35 | 1,572,130 | Direct | |
| Oct 7, 2025 | Common Shares | MOption exerciseAcquired | +107,131 | $7.45 | +$798,125.95 | 1,679,261 | Direct | |
| Oct 7, 2025 | Common Shares | MOption exerciseAcquired | +180,859 | $3.85 | +$696,307.15 | 1,860,120 | Direct | |
| Oct 7, 2025 | Common Shares | SSaleDisposed | −355,161 | $16.15 | −$5,735,850.15 | 1,504,959 | Direct | |
| Oct 8, 2025 | Common Shares | MOption exerciseAcquired | +10,307 | $15.85 | +$163,365.95 | 1,515,266 | Direct | |
| Oct 8, 2025 | Common Shares | MOption exerciseAcquired | +128,295 | $7.45 | +$955,797.75 | 1,643,561 | Direct | |
| Oct 8, 2025 | Common Shares | SSaleDisposed | −138,602 | $16.20 | −$2,245,352.4 | 1,504,959 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | MOption exerciseDisposed | −127,355 | $0.00 | $0 | 1,054,528 | Direct | |
| Oct 6, 2025 | Common Stock | MOption exerciseDisposed | −24,900 | $0.00 | $0 | 235,426 | Direct | |
| Oct 6, 2025 | Common Stock | MOption exerciseDisposed | −19,141 | $0.00 | $0 | 6,457,382 | Direct | |
| Oct 7, 2025 | Common Stock | MOption exerciseDisposed | −67,171 | $0.00 | $0 | 987,357 | Direct | |
| Oct 7, 2025 | Common Stock | MOption exerciseDisposed | −107,131 | $0.00 | $0 | 128,295 | Direct | |
| Oct 7, 2025 | Common Stock | MOption exerciseDisposed | −180,859 | $0.00 | $0 | 6,276,523 | Direct | |
| Oct 8, 2025 | Common Stock | MOption exerciseDisposed | −10,307 | $0.00 | $0 | 977,050 | Direct | |
| Oct 8, 2025 | Common Stock | MOption exerciseDisposed | −128,295 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.